Compile Data Set for Download or QSAR
maximum 50k data
Found 823 of ic50 for UniProtKB: P13807
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635344(US11814367, Compound 794)
Affinity DataIC50:  2nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635336(US11814367, Compound 786)
Affinity DataIC50:  3nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635055(US11814367, Compound 504)
Affinity DataIC50:  3nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635052(US11814367, Compound 501)
Affinity DataIC50:  3nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634965(US11814367, Compound 414)
Affinity DataIC50:  3nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635349(US11814367, Compound 799)
Affinity DataIC50:  4nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635353(US11814367, Compound 803)
Affinity DataIC50:  4nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634940(US11814367, Compound 389)
Affinity DataIC50:  4nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635076(US11814367, Compound 525)
Affinity DataIC50:  4nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635057(US11814367, Compound 506)
Affinity DataIC50:  4nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635066(US11814367, Compound 515)
Affinity DataIC50:  4nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634954(US11814367, Compound 403)
Affinity DataIC50:  4nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635283(US11814367, Compound 733)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635285(US11814367, Compound 735)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635333(US11814367, Compound 783)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635334(US11814367, Compound 784)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635346(US11814367, Compound 796)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634903(US11814367, Compound 352)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635074(US11814367, Compound 523)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634919(US11814367, Compound 368)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634937(US11814367, Compound 386 | US11814367, Compound 77...)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634938(US11814367, Compound 387)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634939(US11814367, Compound 388 | US11814367, Compound 77...)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634943(US11814367, Compound 392)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635073(US11814367, Compound 522)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634905(US11814367, Compound 354)
Affinity DataIC50:  5nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635299(US11814367, Compound 749)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635335(US11814367, Compound 785)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635342(US11814367, Compound 792)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635356(US11814367, Compound 806)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634845(US11814367, Compound 294)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635100(US11814367, Compound 549)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634929(US11814367, Compound 378)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634942(US11814367, Compound 391)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634955(US11814367, Compound 404)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634964(US11814367, Compound 413)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635075(US11814367, Compound 524)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634926(US11814367, Compound 375)
Affinity DataIC50:  6nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635337(US11814367, Compound 787)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635341(US11814367, Compound 791)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635359(US11814367, Compound 809 | US11814367, Compound 81...)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634681(US11814367, Compound 130)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634808(US11814367, Compound 257)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634870(US11814367, Compound 319)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635102(US11814367, Compound 551)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634916(US11814367, Compound 365)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634945(US11814367, Compound 394)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM634963(US11814367, Compound 412)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635065(US11814367, Compound 514)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen [starch] synthase, muscle(Homo sapiens (Human))
Maze Therapeutics

US Patent
LigandPNGBDBM635078(US11814367, Compound 527)
Affinity DataIC50:  7nMAssay Description:Compounds that inhibit the hGYS1 enzyme and, subsequently, the downstream conversion of NADH to NAD+, were tested using assay ready plates (black, cl...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 823 total ) | Next | Last >>
Jump to: